ATE501144T1 - Triaza- und tetraaza-anthrazendionderivate, ihre herstellung und verwendung als pharmazeutika - Google Patents
Triaza- und tetraaza-anthrazendionderivate, ihre herstellung und verwendung als pharmazeutikaInfo
- Publication number
- ATE501144T1 ATE501144T1 AT04726960T AT04726960T ATE501144T1 AT E501144 T1 ATE501144 T1 AT E501144T1 AT 04726960 T AT04726960 T AT 04726960T AT 04726960 T AT04726960 T AT 04726960T AT E501144 T1 ATE501144 T1 AT E501144T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- phenyl
- triaza
- tetraaza
- pyridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20030009286 EP1471066A1 (de) | 2003-04-24 | 2003-04-24 | Triaza- und Tetraaza-anthrazendionderivate, ihre Herstellung und Verwendung als Pharmazeutika |
PCT/EP2004/003851 WO2004094425A1 (en) | 2003-04-24 | 2004-04-13 | Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE501144T1 true ATE501144T1 (de) | 2011-03-15 |
Family
ID=32946872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04726960T ATE501144T1 (de) | 2003-04-24 | 2004-04-13 | Triaza- und tetraaza-anthrazendionderivate, ihre herstellung und verwendung als pharmazeutika |
Country Status (13)
Country | Link |
---|---|
EP (2) | EP1471066A1 (de) |
JP (1) | JP4603530B2 (de) |
AT (1) | ATE501144T1 (de) |
AU (1) | AU2004232456B2 (de) |
BR (1) | BRPI0409698A (de) |
CA (1) | CA2523196C (de) |
DE (1) | DE602004031734D1 (de) |
DK (1) | DK1641795T3 (de) |
ES (1) | ES2362658T3 (de) |
IL (1) | IL171500A (de) |
MX (1) | MXPA05011267A (de) |
PT (1) | PT1641795E (de) |
WO (1) | WO2004094425A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7238702B2 (en) | 2005-02-10 | 2007-07-03 | Bristol-Myers Squibb Company | Dihydroquinazolinones as 5HT modulators |
EP1741708A1 (de) | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl substituierte Amide mit ungesättigtem oder zyklischem Linker, und deren Verwendung als Pharmaka |
EP1741709A1 (de) | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl substituierte Amide mit gesättigtem Linker, und deren Verwendung als Pharmaka |
EP1905764A1 (de) | 2006-09-30 | 2008-04-02 | Sanofi-Aventis | Substituierte 2-Phenylbenzimidazole und ihre Verwendung als Pharmazeutika |
EP1923062A1 (de) | 2006-11-16 | 2008-05-21 | sanofi-aventis | Imidazo[2,1-b]thiazole und ihre Verwendung als Pharmazeutika |
EP1942104A1 (de) | 2006-12-20 | 2008-07-09 | sanofi-aventis | Heteroarylcyclopropancarbonsäureamide und deren pharmazeutische Verwendung |
EP1939180A1 (de) | 2006-12-20 | 2008-07-02 | sanofi-aventis | Heteroarylacrylamide und ihre Verwendung als Arzneimittel für die Stimulation der Expression der endothelialen NO-Synthase |
EP1939181A1 (de) | 2006-12-27 | 2008-07-02 | sanofi-aventis | Heteroaryl-substituierte Carboxamide und deren Verwendung für die Stimulierung der NO Synthase Expression |
EP1964841A1 (de) | 2007-02-28 | 2008-09-03 | sanofi-aventis | Imidazo[1,2-a]azine und deren pharmazeutische Verwendung |
EP1964840A1 (de) | 2007-02-28 | 2008-09-03 | sanofi-aventis | Imidazo[1,2-a]pyridine und deren pharmazeutische Verwendung |
GB2575490A (en) * | 2018-07-12 | 2020-01-15 | Recordati Ind Chimica E Farmaceutica Spa | P2X3 receptor antagonists |
WO2021048364A1 (en) * | 2019-09-11 | 2021-03-18 | Solvay Sa | Process for manufacturing a substituted cyclohexanecarbonitrile |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294517B1 (en) * | 1996-02-02 | 2001-09-25 | Nitromed, Inc. | Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
PE20020856A1 (es) * | 2001-02-13 | 2002-11-11 | Aventis Pharma Gmbh | 1,2,3,4-tetrahidronaftil aminas aciladas |
-
2003
- 2003-04-24 EP EP20030009286 patent/EP1471066A1/de not_active Withdrawn
-
2004
- 2004-04-13 BR BRPI0409698-3A patent/BRPI0409698A/pt not_active IP Right Cessation
- 2004-04-13 AU AU2004232456A patent/AU2004232456B2/en not_active Ceased
- 2004-04-13 PT PT04726960T patent/PT1641795E/pt unknown
- 2004-04-13 ES ES04726960T patent/ES2362658T3/es not_active Expired - Lifetime
- 2004-04-13 MX MXPA05011267A patent/MXPA05011267A/es active IP Right Grant
- 2004-04-13 CA CA2523196A patent/CA2523196C/en not_active Expired - Fee Related
- 2004-04-13 AT AT04726960T patent/ATE501144T1/de active
- 2004-04-13 WO PCT/EP2004/003851 patent/WO2004094425A1/en active Application Filing
- 2004-04-13 DE DE602004031734T patent/DE602004031734D1/de not_active Expired - Lifetime
- 2004-04-13 DK DK04726960.0T patent/DK1641795T3/da active
- 2004-04-13 JP JP2006505091A patent/JP4603530B2/ja not_active Expired - Fee Related
- 2004-04-13 EP EP04726960A patent/EP1641795B1/de not_active Expired - Lifetime
-
2005
- 2005-10-20 IL IL171500A patent/IL171500A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4603530B2 (ja) | 2010-12-22 |
IL171500A (en) | 2010-06-30 |
PT1641795E (pt) | 2011-05-18 |
CA2523196C (en) | 2012-05-29 |
EP1641795B1 (de) | 2011-03-09 |
MXPA05011267A (es) | 2006-05-25 |
EP1641795A1 (de) | 2006-04-05 |
JP2006524197A (ja) | 2006-10-26 |
WO2004094425A1 (en) | 2004-11-04 |
DK1641795T3 (da) | 2011-06-27 |
ES2362658T3 (es) | 2011-07-11 |
EP1471066A1 (de) | 2004-10-27 |
AU2004232456A1 (en) | 2004-11-04 |
CA2523196A1 (en) | 2004-11-04 |
DE602004031734D1 (de) | 2011-04-21 |
AU2004232456B2 (en) | 2010-06-17 |
BRPI0409698A (pt) | 2006-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE501144T1 (de) | Triaza- und tetraaza-anthrazendionderivate, ihre herstellung und verwendung als pharmazeutika | |
ES2805087T3 (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la cinasa RET | |
AU2004309279B2 (en) | Thiazole derivative | |
AU2015320675B2 (en) | Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds | |
CA2787291C (en) | 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds | |
EP2097413B1 (de) | 2-[(2-substituierte)indolizin-3-yl]-2-oxoacetamidderivate als antipilzmittel | |
DK2350090T3 (en) | Spiro-oxindole compounds and their use as therapeutic agents | |
DK1921077T3 (en) | Means for treating and / or preventing sleep disorders | |
JP6080226B2 (ja) | 他の活性物質と組み合わせたロイコトリエン産生阻害用ベンゾジオキサン | |
EA035049B1 (ru) | СОЕДИНЕНИЯ ЗАМЕЩЕННОГО ПИРАЗОЛО[1,5-a]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ RET КИНАЗЫ | |
HRP20140770T1 (hr) | SUPSTITUIRANI SPOJEVI N-(1H-INDAZOL-4-IL)IMIDAZO[1,2-a]PIRIDIN-3-KARBOKSAMIDA KAO INHIBITORI CFMS | |
CA2863985C (en) | Furo [3,2-b] - and thieno [3,2-b] pyridine derivatives as tbk1 and ikk inhibitors | |
RU2008125068A (ru) | Спироциклические соединения | |
KR20190075931A (ko) | 스피로 고리 화합물 | |
JP2013515070A5 (de) | ||
JP2009516743A5 (de) | ||
KR20130132393A (ko) | 고리-융합된 피리미딘 및 트리아진, 및 심혈관 질환의 치료 및/또는 예방을 위한 그의 용도 | |
JP2011516512A5 (ja) | 新規な置換スピロ[シクロアルキル−1,3'−インドール]−2'(1'H)−オン誘導体およびp38マイトジェン活性化タンパク質キナーゼ阻害剤としてのそれらの使用 | |
JP2007536252A5 (de) | ||
KR20080098070A (ko) | 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘 | |
TW202214598A (zh) | 快速加速纖維肉瘤蛋白質降解之化合物及相關使用方法 | |
JP2023545545A (ja) | 複素環スピロ化合物及び使用方法 | |
EA037598B1 (ru) | Производные 3-((гетеро-)арил)-8-амино-2-оксо-1,3-диазаспиро[4,5]декана | |
CN116848107A (zh) | 化合物及其作为pde4激活剂的用途 | |
CN116745295A (zh) | Brm靶向化合物及相关使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1641795 Country of ref document: EP |